Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Sosv
AddedFeb 13, 2024
UpdatedJul 16, 2026
Sosv

Sosv

Operating

SOSV LLC: A global venture capital firm investing in gaming, software, robotics, agritech, e-commerce, and digital health.

Location
Princeton, NJ, US
Founded
1994
Firm
Compare
Portfolio
Employees
News
Website

Investments

Prolific Machines
Prolific Machines
Series C

Total Raised

$147M

Rounds

9

Series C$50MJuly 2026
Series B$55MJune 2024
Medical Devices Corner
Medical Devices Corner
Seed

Rounds

1

SeedJanuary 2026
Zymochem
Zymochem

Total Raised

$29.6M

Rounds

6

Series A$21MJanuary 2024
Feel Therapeutics
Feel Therapeutics

Total Raised

$10.5M

Rounds

5

Series UnknownJanuary 2024
Last Gameboard
Last Gameboard

Total Raised

$7.1M

Rounds

6

SeedDecember 2023
Sun Genomics
Sun Genomics

Total Raised

$12.2M

Rounds

9

Series BDecember 2023
Lura Health
Lura Health

Total Raised

$2.5M

Rounds

6

SeedDecember 2023
unlocked labs
unlocked labs

Total Raised

$1.7M

Rounds

8

SeedDecember 2023
Qnetic
Qnetic

Total Raised

$1.5M

Rounds

3

SeedDecember 2023
Rightbot
Rightbot

Total Raised

$6.8M

Rounds

5

Seed$6.3MDecember 2023
Lingrove
Lingrove

Total Raised

$15.7M

Rounds

6

Series B$10.1MNovember 2023
Prellis Biologics
Prellis Biologics

Total Raised

$79.4M

Rounds

11

Series CNovember 2023
TômTex
TômTex

Total Raised

$4.2M

Rounds

5

Seed$2.3MNovember 2023
Hypercell Technologies
Hypercell Technologies

Total Raised

$1M

Rounds

2

SeedNovember 2023
Bite
Bite

Total Raised

$10.5M

Rounds

9

Series A$1kNovember 2023
Lillianah
Lillianah

Total Raised

$40k

Rounds

3

SeedOctober 2023
Gozen
Gozen

Total Raised

$3.3M

Rounds

1

Seed$3.3MOctober 2023
ViaBot
ViaBot

Total Raised

$9.7M

Rounds

5

SeedOctober 2023
RizLab Health
RizLab Health

Total Raised

$331k

Rounds

5

Convertible NoteOctober 2023
Simply Good Jars
Simply Good Jars
Public

Total Raised

$8.5M

Rounds

9

Series ASeptember 2023
BioAesthetics
BioAesthetics

Total Raised

$6.7M

Rounds

7

Convertible NoteSeptember 2023
Particle
Particle
Series C

Total Raised

$105.8M

Rounds

15

Series CSeptember 2023
Gatehouse Bio
Gatehouse Bio

Total Raised

$7.9M

Rounds

7

Convertible NoteSeptember 2023
Earnest Agriculture
Earnest Agriculture

Total Raised

$1.1M

Rounds

3

Seed$750kSeptember 2023